Agency Information Collection Activities: Submission for OMB Review; Comment Request, 68785-68787 [2012-27841]
Download as PDF
Federal Register / Vol. 77, No. 222 / Friday, November 16, 2012 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Institute for Occupational Safety and
Health (NIOSH) intends to employ
existing provisions in 42 CFR Part 84 to
test and approve air-purifying
respirators (APRs) and powered airpurifying respirators (PAPRs) that
provide composite multi-gas and
particulate protection for inhalation
hazards associated with wildland firefighting. NIOSH will evaluate candidate
respirators for inhalation protections
tailored against exposures identified in
the National Fire Protection Association
(NFPA) 1984 standard on respirators for
wildland fire-fighting (WFF) operations.
Under 42 CFR Part 84 requirements,
NIOSH approval is necessary for the
complete evaluation of WFF respirators
pursuant to NFPA 1984 (2011).
SUPPLEMENTARY INFORMATION:
Background
Wildland firefighting presents many
hazards to firefighters, including
inhalation exposure to smoke and other
combustion (fire) byproducts. Studies
indicate that most wildland firefighters
work in smoke levels that are not
expected to cause health problems or
exceed legal and recommended limits.1
However, wildland firefighters
occasionally experience smoke levels
that exceed guidelines recommended by
occupational health experts, and are
higher than Federal occupational safety
and health regulations allow. Because
manufacturers have not yet developed
respiratory protection for this
occupational setting, firefighters battling
wild fires often resort to using devices
not approved by NIOSH, or NIOSHapproved filtering facepiece respirators
which are not designed for this use, or
no respiratory protection at all. Without
a NIOSH-approved respirator designed
to protect against the combination of
particulates, gases and vapors generally
produced by wildfires, firefighters
cannot be sure that they are receiving
adequate or any protection at all.
Filtering facepiece respirators approved
under the current NIOSH standards
provide no protection against fire gases
or vapors and may structurally fail at
the elevated temperatures encountered
in wildland firefighting environments.
NIOSH is now accepting applications
for respiratory protective devices
designed for the inhalation hazards of
this occupational setting.
On July 10, 2012 NIOSH issued a
letter to manufacturers 2 announcing
that NIOSH was prepared to evaluate
respirators used for protection against
1 See: Reinhardt,TE, Ottmar, RD. 2000. Smoke
exposure at western wildfires. Res. Pap. PNW–RP–
525. Portland, OR: U.S. Department of Agriculture,
Forest Service, Pacific Northwest Research Station.
VerDate Mar<15>2010
15:43 Nov 15, 2012
Jkt 229001
the inhalation hazards identified in the
National Fire Protection Association
(NFPA) standard 1984 (2011 Edition).3
This new evaluation will be conducted
in accordance with a Memorandum of
Understanding between the NIOSH
National Personal Protective
Technology Laboratory (NPPTL) and the
Safety Equipment Institute (SEI), a nongovernmental non-profit organization
that administers third-party certification
programs to certify a broad range of
safety and protective products. Under
this MOU, NIOSH/NPPTL and SEI will
coordinate their certification programs.
SEI will evaluate candidate respirators
for compliance with NFPA 1984–2011,
Standard on Respirators for Wildland
Fire-Fighting Operations, which
includes Tentative Interim Amendment
(TIA) No. 11–1.
Under NFPA 1984, the wildland
firefighter respirator must be approved
by NIOSH as an APR or a PAPR. NIOSH
has developed test procedures for a
composite particulate and multi-gas
protection for APR and PAPR approvals
in accordance with 42 CFR 84.60(b);
84.63(a), (b), (c), and (d); 84.110(c); and
84.190(b). The standard test procedures
are available upon request and will be
available on the NIOSH NPPTL Web site
at: https://www.cdc.gov/niosh/npptl/
stps/APresp.html.
FOR FURTHER INFORMATION CONTACT: Tim
Rehak, NIOSH National Personal
Protective Technology Laboratory
(NPPTL), P.O. Box 18070, 626 Cochrans
Mill Road, Pittsburgh, PA 15236; (412)
386–5200 (this is not a toll-free
number).
Dated: November 8, 2012.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2012–27898 Filed 11–15–12; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10028, CMS–
10180, CMS–R–199 and CMS–10443]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
AGENCY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
68785
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Children’s
Health Insurance Program (CHIP) Report
on Payables and Receivables; Use:
Collection of CHIP data and the
calculation of the CHIP Incurred But
Not Reported (IBNR) estimate are
pertinent to CMS’ financial audit. The
CFO auditors have reported the lack of
an estimate for CHIP IBNR payables and
receivables as a reportable condition in
the FY 2005 audit of CMS’s financial
statements. It is essential that CMS
collect the necessary data from State
agencies in FY 2006, so that CMS
continues to receive an unqualified
audit opinion on its financial
statements. Program expenditures for
the CHIP have increased since its
inception; as such, CHIP receivables and
payables may materially impact the
financial statements. The CHIP Report
on Payables and Receivables will
provide the information needed to
calculate the CHIP IBNR.; Form
Number: CMS–10180 (OMB#: 0938–
0988); Frequency: Reporting—Annually;
Affected Public: State, Local or Tribal
governments; Number of Respondents:
56; Total Annual Responses: 56; Total
Annual Hours: 392. (For policy
questions regarding this collection
contact Michele Myers at 410–786–
7911. For all other issues call 410–786–
1326.)
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicaid Report
on Payables and Receivables; Use: The
Chief Financial Officers (CFO) Act of
1990, as amended by the Government
Management Reform Act (GMRA) of
1994, requires government agencies to
produce auditable financial statements.
Because the Centers for Medicare &
Medicaid Services (CMS) fulfills its
E:\FR\FM\16NON1.SGM
16NON1
mstockstill on DSK4VPTVN1PROD with NOTICES
68786
Federal Register / Vol. 77, No. 222 / Friday, November 16, 2012 / Notices
mission through its contractors and the
States; these entities are the primary
source of information for the financial
statements. There are three basic
categories of data: expenses, payables,
and receivables. The CMS–64 is used to
collect data on Medicaid expenses. The
CMS–R–199 collects Medicaid payable
and receivable accounting data from the
States. Form Number: CMS–R–199
(OMB#: 0938–0697); Frequency:
Reporting—Annually; Affected Public:
State, Local or Tribal governments;
Number of Respondents: 56; Total
Annual Responses: 56; Total Annual
Hours: 336. (For policy questions
regarding this collection contact
Michele Myers at 410–786–7911. For all
other issues call 410–786–1326.)
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: State Health
Insurance Assistance Program (SHIP)
Client Contact Form, Public and Media
Activity Report Form, and Resource
Report Form. Use: Section 4360(f) of the
Omnibus Budget Reconciliation Act
(OBRA) 1990 requires the Secretary to
provide a series of reports to the U.S.
Congress on the performance of the
program and its impact on beneficiaries
and to obtain important informational
feedback from beneficiaries. Further, in
response to requirements of the
Balanced Budget Act of 1997, CMS
launched a comprehensive five-year
campaign, the National Medicare
Education Program (NMEP), to raise
awareness among beneficiaries about
their Medicare health plan options and
help them assess the advantages and
disadvantages each choice holds for
them. The Medicare Modernization Act
(MMA) of 2003 required State Health
Insurance Assistance Programs (SHIPs)
to be actively engaged in the
implementation of the Medicare
Prescription Drug Program (Part D).
MIPPA legislation and Affordable Care
Act legislation required SHIPs to
provide enrollment assistance for the
Limited Income Subsidy (LIS) and
Medicare Savings Program (MSP). The
goal is to ensure that beneficiaries are
making an informed choice, regardless
of whether they stay in Original
Medicare or choose new options. CMS
is responsible to Congress for
demonstrating improvement over time
in the level of awareness and
understanding beneficiaries have about
health plan options. The SHIPs are an
integral component of this initiative.
The information collected is used to
fulfill the reporting requirements
described in Section 4360(f) of OBRA
1990. CMS will utilize this data. The
VerDate Mar<15>2010
15:43 Nov 15, 2012
Jkt 229001
data will be accumulated and analyzed
to measure SHIP performance in order
to determine whether and to what
extent the SHIPs have met the goals of
improved CMS customer service to
beneficiaries and better understanding
by beneficiaries of their health
insurance options. Further, the
information will be used in the
administration of the grants, to measure
performance and appropriate use of the
funds by the state grantees, to identify
gaps in services and technical support
needed by SHIPs, and to identify and
share best practices.
The overall burden of hours and
expected number of respondents
increase is based on projected future
service growth and projected future
increases in staffing to accommodate the
increased demand to utilize the SHIP
network to raise awareness about new
CMS policies, outreach initiatives, or
both. However, the instruments
themselves have not changed. Form
Number: CMS–10028 (OCN: 0938–
0850); Frequency: Occasionally;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
17,838; Total Annual Responses:
2,346,465. Total Annual Hours: 195,642.
(For policy questions regarding this
collection contact Gregory Price at 410–
786–4041. For all other issues call 410–
786–1326.)
4. Type of Information Collection
Request: New collection. Title of
Information Collection: Transcatheter
Valve Therapy Registry and KCCQ–10.
Use: The data collection is required by
the Centers for Medicare and Medicaid
Services (CMS) National Coverage
Determination (NCD) entitled,
‘‘Transcatheter Aortic Valve
Replacement (TAVR)’’. The TAVR
device is only covered when specific
conditions are met including that the
heart team and hospital are submitting
data in a prospective, national, audited
registry. The data includes patient,
practitioner and facility level variables
that predict outcomes such as all cause
mortality and quality of life. CMS finds
that the Society of Thoracic Surgery/
American College of Cardiology
Transcatheter Valve Therapy (STS/ACC
TVT) Registry, one registry overseen by
the National Cardiovascular Data
Registry, meets the requirements
specified in the NCD on TAVR. The
TVT Registry will support a national
surveillance system to monitor the
safety and efficacy of the TAVR
technologies for the treatment of aortic
stenosis.
The data will also include the
variables on the eight item Kansas City
Cardiomyopathy Questionnaire (KCCQ–
10) to assess heath status, functioning
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
and quality of life. In the KCCQ, an
overall summary score can be derived
from the physical function, symptoms
(frequency and severity), social function
and quality of life domains. For each
domain, the validity, reproducibility,
responsiveness and interpretability have
been independently established. Scores
are transformed to a range of 0–100, in
which higher scores reflect better health
status.
The conduct of the STS/ACC TVT
Registry and the KCCQ–10 is in
accordance with Section 1142 of the
Social Security Act (the Act) that
describes the authority of the Agency for
Healthcare Research and Quality
(AHRQ). Under section 1142, research
may be conducted and supported on the
outcomes, effectiveness, and
appropriateness of health care services
and procedures to identify the manner
in which disease, disorders, and other
health conditions can be prevented,
diagnosed, treated, and managed
clinically. Section 1862(a)(1)(E) of the
Act allows Medicare to cover under
coverage with evidence development
(CED) certain items or services for
which the evidence is not adequate to
support coverage under section
1862(a)(1)(A) and where additional data
gathered in the context of a clinical
setting would further clarify the impact
of these items and services on the health
of beneficiaries.
The data collected and analyzed in
the TVT Registry will be used by CMS
to determine if the TAVR is reasonable
and necessary (e.g., improves health
outcomes) for Medicare beneficiaries
under Section 1862(a)(1)(A) of the Act.
Furthermore, data from the Registry will
assist the medical device industry and
the Food and Drug Administration
(FDA) in surveillance of the quality,
safety and efficacy of new medical
devices to treat aortic stenosis. For
purposes of the TAVR NCD, The TVT
Registry has contracted with the Data
Analytic Centers to conduct the
analyses. In addition, data will be made
available for research purposes under
the terms of a data use agreement that
only provides de-identified datasets.
Form Number: CMS–10443 (OCN: 0938New); Frequency: Annual; Affected
Public: Individuals, Households and
Private Sector; Number of Respondents:
12,000; Total Annual Responses:
24,000; Total Annual Hours: 7,000. (For
policy questions regarding this
collection contact JoAnna Baldwin at
410–786–7205. For all other issues call
410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web site
E:\FR\FM\16NON1.SGM
16NON1
Federal Register / Vol. 77, No. 222 / Friday, November 16, 2012 / Notices
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email
your request, including your address,
phone number, OMB number, and CMS
document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on December 17, 2012. OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–6974, Email:
OIRA_submission@omb.eop.gov.
Dated: November 9, 2012.
Martique Jones,
Director, Regulations Development Group,
Division B, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2012–27841 Filed 11–15–12; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–D–0164]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Draft Guidance for
Industry on Safety Labeling Changes;
Implementation of the Federal Food,
Drug, and Cosmetic Act
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
SUMMARY:
68787
Act. FDA plans to request safety
labeling changes by sending a
notification letter to the application
holder. Under section 505(o)(4)(B) of the
FD&C Act (21 U.S.C. 355(o)(4)(B)), the
application holder must respond to
FDA’s notification by submitting a
labeling supplement or notifying FDA
that the applicant does not believe the
labeling change is warranted and
submitting a statement detailing the
reasons why the application holder does
not believe a change is warranted (a
rebuttal statement).
The submission of rebuttal statements
may result in the collection of
information that is not already approved
by OMB. Based on FDA’s experience
thus far with safety labeling changes
requirements under section 505(o)(4) of
the FD&C Act, FDA estimates that
approximately six application holders
will elect to submit approximately one
rebuttal statement each year and that
each rebuttal statement will take
approximately 6 hours to prepare.
In addition, in the draft guidance, the
Agency states that new labeling
prepared in response to a safety labeling
change notification should be available
on the application holder’s Web site
within 10 calendar days of approval,
which may result in the collection of
information that is not already approved
by OMB. FDA estimates that
approximately 197 application holders
will post new labeling one time each
year in response to a safety labeling
change notification and that the posting
of the labeling will take approximately
4 hours to prepare.
In the Federal Register of April 13,
2011 (76 FR 20686), FDA published a
60-day notice requesting public
comment on the draft version of this
guidance. None of the comments we
received pertained to the information
collection provisions.
FDA estimates the burden of the
collections of information that have not
already been approved by OMB is as
follows:
the Paperwork Reduction Act of 1995
(the PRA).
DATES: Fax written comments on the
collection of information by December
17, 2012.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Draft Guidance for Industry on
Safety Labeling Changes;
Implementation of Section 505(o)(4) of
the Federal Food, Drug, and Cosmetic
Act.’’ Also include the FDA docket
number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7726, Ila.Mizrachi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Draft Guidance for Industry on Safety
Labeling Changes; Implementation of
Section 505(o)(4) of the Federal Food,
Drug, and Cosmetic Act—(OMB Control
Number 0910-New)
This draft guidance provides
information on the implementation of
section 901 of the Food and Drug
Administration Amendments Act of
2007, which authorizes FDA to require
certain drug and biological product
application holders to make safety
related labeling changes based upon
new safety information that becomes
available after the drug or biological
product is approved under the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) or the Public Health Service
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total hours
6
1
6
6
36
mstockstill on DSK4VPTVN1PROD with NOTICES
Rebuttal statement ...........................................
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Mar<15>2010
15:43 Nov 15, 2012
Jkt 229001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\16NON1.SGM
16NON1
Agencies
[Federal Register Volume 77, Number 222 (Friday, November 16, 2012)]
[Notices]
[Pages 68785-68787]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27841]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier CMS-10028, CMS-10180, CMS-R-199 and CMS-10443]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS), Department of Health and Human Services, is publishing
the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the Agency's function; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
1. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Children's Health
Insurance Program (CHIP) Report on Payables and Receivables; Use:
Collection of CHIP data and the calculation of the CHIP Incurred But
Not Reported (IBNR) estimate are pertinent to CMS' financial audit. The
CFO auditors have reported the lack of an estimate for CHIP IBNR
payables and receivables as a reportable condition in the FY 2005 audit
of CMS's financial statements. It is essential that CMS collect the
necessary data from State agencies in FY 2006, so that CMS continues to
receive an unqualified audit opinion on its financial statements.
Program expenditures for the CHIP have increased since its inception;
as such, CHIP receivables and payables may materially impact the
financial statements. The CHIP Report on Payables and Receivables will
provide the information needed to calculate the CHIP IBNR.; Form
Number: CMS-10180 (OMB: 0938-0988); Frequency: Reporting--
Annually; Affected Public: State, Local or Tribal governments; Number
of Respondents: 56; Total Annual Responses: 56; Total Annual Hours:
392. (For policy questions regarding this collection contact Michele
Myers at 410-786-7911. For all other issues call 410-786-1326.)
2. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Medicaid Report
on Payables and Receivables; Use: The Chief Financial Officers (CFO)
Act of 1990, as amended by the Government Management Reform Act (GMRA)
of 1994, requires government agencies to produce auditable financial
statements. Because the Centers for Medicare & Medicaid Services (CMS)
fulfills its
[[Page 68786]]
mission through its contractors and the States; these entities are the
primary source of information for the financial statements. There are
three basic categories of data: expenses, payables, and receivables.
The CMS-64 is used to collect data on Medicaid expenses. The CMS-R-199
collects Medicaid payable and receivable accounting data from the
States. Form Number: CMS-R-199 (OMB: 0938-0697); Frequency:
Reporting--Annually; Affected Public: State, Local or Tribal
governments; Number of Respondents: 56; Total Annual Responses: 56;
Total Annual Hours: 336. (For policy questions regarding this
collection contact Michele Myers at 410-786-7911. For all other issues
call 410-786-1326.)
3. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: State Health
Insurance Assistance Program (SHIP) Client Contact Form, Public and
Media Activity Report Form, and Resource Report Form. Use: Section
4360(f) of the Omnibus Budget Reconciliation Act (OBRA) 1990 requires
the Secretary to provide a series of reports to the U.S. Congress on
the performance of the program and its impact on beneficiaries and to
obtain important informational feedback from beneficiaries. Further, in
response to requirements of the Balanced Budget Act of 1997, CMS
launched a comprehensive five-year campaign, the National Medicare
Education Program (NMEP), to raise awareness among beneficiaries about
their Medicare health plan options and help them assess the advantages
and disadvantages each choice holds for them. The Medicare
Modernization Act (MMA) of 2003 required State Health Insurance
Assistance Programs (SHIPs) to be actively engaged in the
implementation of the Medicare Prescription Drug Program (Part D).
MIPPA legislation and Affordable Care Act legislation required SHIPs to
provide enrollment assistance for the Limited Income Subsidy (LIS) and
Medicare Savings Program (MSP). The goal is to ensure that
beneficiaries are making an informed choice, regardless of whether they
stay in Original Medicare or choose new options. CMS is responsible to
Congress for demonstrating improvement over time in the level of
awareness and understanding beneficiaries have about health plan
options. The SHIPs are an integral component of this initiative. The
information collected is used to fulfill the reporting requirements
described in Section 4360(f) of OBRA 1990. CMS will utilize this data.
The data will be accumulated and analyzed to measure SHIP performance
in order to determine whether and to what extent the SHIPs have met the
goals of improved CMS customer service to beneficiaries and better
understanding by beneficiaries of their health insurance options.
Further, the information will be used in the administration of the
grants, to measure performance and appropriate use of the funds by the
state grantees, to identify gaps in services and technical support
needed by SHIPs, and to identify and share best practices.
The overall burden of hours and expected number of respondents
increase is based on projected future service growth and projected
future increases in staffing to accommodate the increased demand to
utilize the SHIP network to raise awareness about new CMS policies,
outreach initiatives, or both. However, the instruments themselves have
not changed. Form Number: CMS-10028 (OCN: 0938-0850); Frequency:
Occasionally; Affected Public: State, Local, or Tribal Governments;
Number of Respondents: 17,838; Total Annual Responses: 2,346,465. Total
Annual Hours: 195,642. (For policy questions regarding this collection
contact Gregory Price at 410-786-4041. For all other issues call 410-
786-1326.)
4. Type of Information Collection Request: New collection. Title of
Information Collection: Transcatheter Valve Therapy Registry and KCCQ-
10. Use: The data collection is required by the Centers for Medicare
and Medicaid Services (CMS) National Coverage Determination (NCD)
entitled, ``Transcatheter Aortic Valve Replacement (TAVR)''. The TAVR
device is only covered when specific conditions are met including that
the heart team and hospital are submitting data in a prospective,
national, audited registry. The data includes patient, practitioner and
facility level variables that predict outcomes such as all cause
mortality and quality of life. CMS finds that the Society of Thoracic
Surgery/American College of Cardiology Transcatheter Valve Therapy
(STS/ACC TVT) Registry, one registry overseen by the National
Cardiovascular Data Registry, meets the requirements specified in the
NCD on TAVR. The TVT Registry will support a national surveillance
system to monitor the safety and efficacy of the TAVR technologies for
the treatment of aortic stenosis.
The data will also include the variables on the eight item Kansas
City Cardiomyopathy Questionnaire (KCCQ-10) to assess heath status,
functioning and quality of life. In the KCCQ, an overall summary score
can be derived from the physical function, symptoms (frequency and
severity), social function and quality of life domains. For each
domain, the validity, reproducibility, responsiveness and
interpretability have been independently established. Scores are
transformed to a range of 0-100, in which higher scores reflect better
health status.
The conduct of the STS/ACC TVT Registry and the KCCQ-10 is in
accordance with Section 1142 of the Social Security Act (the Act) that
describes the authority of the Agency for Healthcare Research and
Quality (AHRQ). Under section 1142, research may be conducted and
supported on the outcomes, effectiveness, and appropriateness of health
care services and procedures to identify the manner in which disease,
disorders, and other health conditions can be prevented, diagnosed,
treated, and managed clinically. Section 1862(a)(1)(E) of the Act
allows Medicare to cover under coverage with evidence development (CED)
certain items or services for which the evidence is not adequate to
support coverage under section 1862(a)(1)(A) and where additional data
gathered in the context of a clinical setting would further clarify the
impact of these items and services on the health of beneficiaries.
The data collected and analyzed in the TVT Registry will be used by
CMS to determine if the TAVR is reasonable and necessary (e.g.,
improves health outcomes) for Medicare beneficiaries under Section
1862(a)(1)(A) of the Act. Furthermore, data from the Registry will
assist the medical device industry and the Food and Drug Administration
(FDA) in surveillance of the quality, safety and efficacy of new
medical devices to treat aortic stenosis. For purposes of the TAVR NCD,
The TVT Registry has contracted with the Data Analytic Centers to
conduct the analyses. In addition, data will be made available for
research purposes under the terms of a data use agreement that only
provides de-identified datasets. Form Number: CMS-10443 (OCN: 0938-
New); Frequency: Annual; Affected Public: Individuals, Households and
Private Sector; Number of Respondents: 12,000; Total Annual Responses:
24,000; Total Annual Hours: 7,000. (For policy questions regarding this
collection contact JoAnna Baldwin at 410-786-7205. For all other issues
call 410-786-1326.)
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS Web
site
[[Page 68787]]
address at https://www.cms.hhs.gov/PaperworkReductionActof1995, or email
your request, including your address, phone number, OMB number, and CMS
document identifier, to Paperwork@cms.hhs.gov, or call the Reports
Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received by the OMB desk
officer at the address below, no later than 5 p.m. on December 17,
2012. OMB, Office of Information and Regulatory Affairs, Attention: CMS
Desk Officer, Fax Number: (202) 395-6974, Email: OIRA_submission@omb.eop.gov.
Dated: November 9, 2012.
Martique Jones,
Director, Regulations Development Group, Division B, Office of
Strategic Operations and Regulatory Affairs.
[FR Doc. 2012-27841 Filed 11-15-12; 8:45 am]
BILLING CODE 4120-01-P